N
Google TrendLAMINE YAMAL (2000+) — "You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:lamine yamal2000+abdulrahman alfozan500+pope francis500+olise500+delaware vs middle tennessee prediction500+bayern de múnich200+gme1000+flashscore200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Medicxi closes sixth fund" (30 stories)

Top Headline Story

This week in charts: What’s driving biotech’s recent pullback?
Lead StoryBioPharma Divetech
4d ago

This week in charts: What’s driving biotech’s recent pullback?

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxObzVWRUdwRWJnRmFmRHg2RWx5czZLRzdJeUh4M0duYXduVlMwQzhWanNLWnVkbzgtZE11NVZtd2RKbS1IZHctbElQYl9yMlRpeTZFMy1QdHRSVUEtdDlTcloyWFlhVFpxZmNXdEVBSzZWUG1ydjl1VGpZT1hKakVOQ0g1VTZ4OEo3U2VWd2thMVR1YXNZZlM4U0JKMjhjTTB3U3pn?oc=5" target="_blank">This week in charts: What’s driving biotech’s recent pullback?</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
2000+19m ago

lamine yamal

"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words

Filter stories
500+29m ago

abdulrahman alfozan

OpenAI engineer arrested in bugging of executive conference room

Filter stories
500+29m ago

pope francis

The Myth of St. Francis

Filter stories
500+29m ago

olise

Bayern’s Michael Olise sent off for 2 yellow cards within seconds in Champions League

Filter stories

Search Results for "Medicxi closes sixth fund"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds
BioPharma Divetech

Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQUFlDaGREZ0szOUNZSzZOMF9sSXJ2TlFPdmQyQXRoNlNoR28wcXg0SXEyVjk3ZWllRE5pb3pZTXNQVU1OQTgyb1ZzUThPNk92aFFLTmtDbmpTcHFoNU1YdDFfVWw3V1Bya0NpREhTR1hmYkprUl9vdExPVnZOUXJrYjlhVjNhMnhjZHdxeEd1TVNRUQ?oc=5" target="_blank">Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
In the hunt for reverse merger targets, Caribou could be prized game
BioPharma Diveworld

In the hunt for reverse merger targets, Caribou could be prized game

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQNG5wT2dZdjJPQ2lONDB4OVo3YU1jZ3pnb0VNdlJVNlFkdWhKNDZubXRLVFJzS1FRUmFDa2l0UjI5RDdYOWIyZlJRRG9zV0tta1d0U1BrVy1iRnlQdGR2NVpTb3g1bnVEaXd5WnpuQS1rdmw3YnI2amVocmhBY3J3Q1JrV29lVGFhWW5nVk5nWWViZ2ZPRTV2Wi01MFVOTkVwb3d6eXlR?oc=5" target="_blank">In the hunt for reverse merger targets, Caribou could be prized game</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Medicxi closes sixth fund at €500M, touts success of asset-focused mentality
FirstWord Pharmaworld

Medicxi closes sixth fund at €500M, touts success of asset-focused mentality

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE9rS0xFdnRDYkdfbm0wX29jX3A1SlhIaE4zYmI3azJVek8tMTUtTXV4eTZ6Wm1VOUR3ckFlX0lLWFFIeWNFNEtNTVVwTmoyWEwxSjRr?oc=5" target="_blank">Medicxi closes sixth fund at €500M, touts success of asset-focused mentality</a>  <font color="#6f6f6f">FirstWord Pharma</font>

Read Full StoryMore like this
European investor Medicxi secures €500M biotech fund
Fierce Biotechtech

European investor Medicxi secures €500M biotech fund

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPZHV2WWtxSEJYRHFlaERjVGlnTVNiQTBiUHhfQmpqWVE3RjBCVmM4TTFSR3o4S0xnN3FBd1NQQmVHVlVMOVNBZ0txX1JDNTQ1UDdfaS1MVE1FakNBa3FzZ28xeG9JS2tzdlJvU0Z2MkZ2NmhnRDk5aXFuaExodWNTODJERG5yQ3RIOVdPT1Nsb0ZvLXNWdUE?oc=5" target="_blank">European investor Medicxi secures €500M biotech fund</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Medicxi closes $581m Fund V to accelerate asset-centric biotech investments
BioXconomytech

Medicxi closes $581m Fund V to accelerate asset-centric biotech investments

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOSTdaajQ5T05LeEZCT2s2UEFVT1R3MEJBaUI0d1h5UkZlT1pkTHBzZldWTjF1U1JUczRRcVo5T01Ka3pZSEl2NWoxQnJLclhzMTlTd0FmUXVjYWoxdWRIb0plSkVzZEFFdTBlSnc3WURVb3ZzTTNiR0pKVUFBWDdPQTczdElvS3gxSGRGdWRkRGxuSGd6clZaTXVtZ0ZvVWZhY0l6ZENGM3Z1N1JTcjUybTRB?oc=5" target="_blank">Medicxi closes $581m Fund V to accelerate asset-centric biotech investments</a>  <font color="#6f6f6f">BioXconomy</font>

Read Full StoryMore like this
Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’
BioPharma Divetech

Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNbk5zbjZXNEdNbEM1NFQxM296SXNFWHpDUlhKRkNESXkyWXZ0Z1hDdTdUMjF3b0NIeDhHWXppVDg0UVo5UmhRUEVFeGdRRk9MV0ZpSXp4bXlEcmg4QUs4VWViWTVJcWlRRnM0UnF5cnEtMThuanBSdlcyZXRuMUFMWE1WLW5tWHNmbEVVV0RLbmkxdw?oc=5" target="_blank">Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Biotech startup funding gap widens despite rebound in VC investment
BioPharma Divetech

Biotech startup funding gap widens despite rebound in VC investment

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNaGhDM3hXSTRJVjFiQ19JeTRzZmMyRGd5Yng5T2N4c3JHYUJzTWVtSmNGcXdPR0JvSzlUcG1zRG90UHFxVnhxLUViSkVSVU9Qa0cwVnoycWRmVUJYUG9jLU9seDNES0tJaExKaVNwc25mTWpETG5Ia19BdEhxZ2VNZmV3UnFrbHRfQ3V0VS1tOGl3ejVY?oc=5" target="_blank">Biotech startup funding gap widens despite rebound in VC investment</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Cancer, immune drugmakers dominate VC funding so far in 2026
BioPharma Diveworld

Cancer, immune drugmakers dominate VC funding so far in 2026

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPSEJZdUwwdXNZM1hNdW5GbmQ5U09ETnJ2TEJoUFY1S3pvVThxQmhGUFhBNE9yeER3XzNiOUZEV29iN3JfdGp2TVVONWJieHAzQXEtREZVcnlQUXhfbDNUQTVFZHBWcGNzSXFGTVVEa25VVWpLWjlCTVc1MVoxbm5IVmU2NA?oc=5" target="_blank">Cancer, immune drugmakers dominate VC funding so far in 2026</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Judge orders Apple Tree partner to forfeit oversight of venture fund
BioPharma Divetech

Judge orders Apple Tree partner to forfeit oversight of venture fund

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPMldBTzlZa0pac3djMERqaEhNMXpGV0Z1NGtxeU0xZV9ITG9JTU1fZm5HZG1CSGx4VzBfY1dyY3JObzBuaW9NOVA5RkJUQ2NnWUNvNUdTdzlNdWpLanppdmthQlFhQTJQdUR1eExGM0twbWk0c0J6ZjZULXJGYkI3TFdMdlJEZ250ZFBrbk1tMjZuYzRTYXZpSWJTYll4MTVj?oc=5" target="_blank">Judge orders Apple Tree partner to forfeit oversight of venture fund</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M
BioPharma Diveworld

Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQVU9yYjlfblVaaGpQMnZvcGh5VGdObmxTTk1LZlQ4ZlZOMWVvRmJuU210alRKOUZPeWZyNXlJZDdSSl9MdUdCQTU3NFg1NzhnVVVFWGdqSlhUUDFrSkxVNUV6bVFodTRiZFNSb0EzLWJ6ZXJ2OWNobW05eXpEV0FRQU1XRlh2dFdBRU1VRFluNXdNeG5mdnhaVQ?oc=5" target="_blank">Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Vaderis hauls in $152M to test an AKT-targeting drug
BioPharma Divegeneral

Vaderis hauls in $152M to test an AKT-targeting drug

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQNEh2R0lVa19pT2ZET3Y5czVYWWpsNkFXLVJrNzkwOHNpSVI1S2Z4cEhGRUVaTFlXT2VNSzNUbVpHMzE4QU9vQ1lKZGRzeUVTRGNueFFNU3RxMWtST2x5cU1XWFpqVmt0R09uSV9jV0RVT3lmWUwyRkswN3JFOWZIMktPM012ZnNKWnh3X2ZuWW9ydw?oc=5" target="_blank">Vaderis hauls in $152M to test an AKT-targeting drug</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Verge, following trial failure, rebrands its AI drug discovery ambitions
BioPharma Divetech

Verge, following trial failure, rebrands its AI drug discovery ambitions

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOaHBlT0c0dWpPc0ZucFQzSno2ZVl5QURrMEthOHJmeVVFSFlzTmlST2xVQ09oNmZaZjB3Wjg0aTFrMzBJNldBVktNYUxlXy1QYVc4YnVFeWVhVldocFI4aktnY0dYMHlMMWxLaDlpeHlNbzdVMUE3U2NWVU9vZjlzNnFDbTh2eUZoQjg1NXphZ1pHSzgzaERjZQ?oc=5" target="_blank">Verge, following trial failure, rebrands its AI drug discovery ambitions</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Medicxi closes sixth fund to back ‘asset-centric’ startups
BioPharma Diveworld

Medicxi closes sixth fund to back ‘asset-centric’ startups

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNYWl5UlBJWE5tYmhYcFJGbmhKdGdxSEJVZ2prNFhLckNTdTVuUTEzLWxoYzhvYlI5T0hLWjRFaUVwaTA5WFBtUnFucVNIRDhnaXJfS3JsQUc1NjEwbVFjMVdIb2p0QlVHVGMzMjRsLS1GMlZEZ2pQdVJOWUFwZEgwV1dnMFg1VmVXc0M0bF8wNmo1bzQy?oc=5" target="_blank">Medicxi closes sixth fund to back ‘asset-centric’ startups</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Jeito Capital, prominent biotech investor, raises $1.2B for next fund
BioPharma Divetech

Jeito Capital, prominent biotech investor, raises $1.2B for next fund

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQaWExamFuSTBHWUJ3eVpVWmZPSzJrRDRKS2JrMGxzSDhQOVEybEwtT0F3TlllWWVPbkhxMlNsZDFNLW02bEh1SnhiQk1oZUVoNnlOLXdhNkdmUEJCR2NuUUc4ZTI0Y0FZWDZYbm9zeDdpQzRvcjBGUHluRTFUcVV3MjNucjNkZUlzTUg3cjVsVy0?oc=5" target="_blank">Jeito Capital, prominent biotech investor, raises $1.2B for next fund</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
On biotech’s biggest stage, renewed excitement gets a stress test
BioPharma Divetech

On biotech’s biggest stage, renewed excitement gets a stress test

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNQU10ZG41S2Y4djZHQ2YzQm1XNlBRRlliV2NsMFFrX1NZRnpYdk5rTWptU01VbWd3LWhlY1JoWC1WM25ITVQwajV6ZTJLYkF0SVJEcXUyNUpmWWZZbHZlM3V3emNoUTZHanl5Tnp2WFNrWFAxbDBBM2Z1MnlyRVNTcl96Mi1YZkozZ1gtSDNWQkQyMFRpOWVrUg?oc=5" target="_blank">On biotech’s biggest stage, renewed excitement gets a stress test</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Sofinnova Partners raises another $750M to back biotech, medtech startups
BioPharma Divetech

Sofinnova Partners raises another $750M to back biotech, medtech startups

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQY2pwTmh6S3plX3NpMTQ4M3FvQW5mbDJUUldIN0RBa2JqZE1mQ0k0QWpST3pDM2E0V2ZEbjBoajlDTjA5b0JlV0lBNklYSjJxT0JHbHpURGRkRlozUW8wc3I1bk9zX2wxbFFvZ3BwcFdXY0tqOUdqX2dWR0pBRWltbnpWZWNvSExUekxhbDFrbzNxMU1RRVBaczR6V2hZM3B6?oc=5" target="_blank">Sofinnova Partners raises another $750M to back biotech, medtech startups</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Altesa, run by former Trump official, raises $75M for well-traveled lung drug
BioPharma Divetech

Altesa, run by former Trump official, raises $75M for well-traveled lung drug

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPWXIyTnhEWnl2WVRXVVBmaWZpcVZNbF91em1OT05mN1RFS2xaa3hGbEZmMnhOMmdOLUwyTDkwOEFnMWM3YWk2ZFd5VnN5d1l0M095SFdOQWFHcFdfTDZmNDBMY2R5SnpJRzNfRDlta29hanBIQ2FlRmRHMjNUZklOR1E4a3A3WlNEUG9jSU5sTWpyUW9kOTBJMDVYOTFUbUdVZjZOM3VR?oc=5" target="_blank">Altesa, run by former Trump official, raises $75M for well-traveled lung drug</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
An Arch-backed biotech raises $53M to fight neurodegeneration
BioPharma Divetech

An Arch-backed biotech raises $53M to fight neurodegeneration

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOT1BpTjcyZk05S2JqNHIyS2tPdUZlWW01MFFzZEFIZENfcDZPcTdvRjRrUnFsMUtaV1NfN1FXY2laQnVZLVJ5aHpqMGhNTUEwLXFPY3pTMDVDQjF5YUJ5eW96QkVZaWEwVWY2Tnd4UmloMk11empiaUpEYTZUYlhmS3RYeGdTUk5XcUx3bmZuaVQ3eG5vLTg5NA?oc=5" target="_blank">An Arch-backed biotech raises $53M to fight neurodegeneration</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Takeda, Iambic partner in latest pharma AI push
BioPharma Divetech

Takeda, Iambic partner in latest pharma AI push

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOOExZRFJRZ3lheFdmbzVBSmZjTFR4TkJxaGZ2TEhodlZWelVpTVZfQzFkZU1tb3dNZ3dUOTh6dXMtdXVqY1hVQ2N3MS1EMGpIMnlQd0JnYnBqMTJRM201X0x6aU9kaDR1UUFoWUhuWVZlT3g4cEk1aFdicHBGVUVPSjdwcG1Cemd5dFNGc3FBa2c?oc=5" target="_blank">Takeda, Iambic partner in latest pharma AI push</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Blackstone’s latest life sciences fund raises the bar at $6.3bn
Alternatives Watchtech

Blackstone’s latest life sciences fund raises the bar at $6.3bn

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOR0Fxem1YNndDZnVFV2pHSktfYWJZWHpyQjFCbzdNbXVKSTA1V01ScWpQTGkzNC1Ld3BmYmZQWkNzWlVZdHJoal95cy1hRnk0aURFUU1JNFBYQUh1SmxYR0hYU1NIWXlrT0pjNTh4Q09XM1BmdnppT0VEdXVpZjFma0NFNTVxSFZpejFTQ1c0NWFERUg4VWc?oc=5" target="_blank">Blackstone’s latest life sciences fund raises the bar at $6.3bn</a>  <font color="#6f6f6f">Alternatives Watch</font>

Read Full StoryMore like this
Sofinnova Partners raises €650m for early-stage biotechs
pharmaphorumtech

Sofinnova Partners raises €650m for early-stage biotechs

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOb1JxYnRxX3ZmTGFfMGZGUk91Y2h4VGRVRFludWNsNTJQSDVxUmVIM2xxVVU5TTUzajFXRFV2YUY4bWJLS1dvRFE0THpRVWl6bVU5ZXA3YWlVR21kQUFJV2R1UmdUd3YyRTVUU0tFN3lKVmVUQWpldG9yRFFZaHpvUndvQXlPb3F1VVkw?oc=5" target="_blank">Sofinnova Partners raises €650m for early-stage biotechs</a>  <font color="#6f6f6f">pharmaphorum</font>

Read Full StoryMore like this
Enveda, an AI drugmaker, banks $311M in venture funding
BioPharma Divetech

Enveda, an AI drugmaker, banks $311M in venture funding

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNUS1Sb0UyVEk1ZGZ2cXBIWDQ5ZDlLQ010bmlsQUJFZnoxaWwxZkNNRHdPcTlGeEZDTEJ4d280VkNPd2NaclRESWN1LWtOUG5tckFKNnFSTjNaeE5KZHF4S1VlUWp3Q2VaMEF2M2l0d3FFcnJLMHlBcG5lQTBOaWhQSkdR?oc=5" target="_blank">Enveda, an AI drugmaker, banks $311M in venture funding</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer
BioPharma Divetech

Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQbndfd05fd3h6ZjNiZDlvSUE0Zm80ZzVQcVNFSW5Vel9YNGZ4dTd1NVZsQnhLZ1BpR2g2VG14NnMyX3c0VkhDb0xkcGlPbkpaZnpTc2FEX3dzNDdrOVVsbjItSHV1aWpTNk1lbElYMFNmanplM0cyWXFCWHU4dmJ2MXdnaEVqZ3JFRlFSY1hsUXQwdVYyV2U3MFdUNy1xU1dyM1dQaWQ4Vk1lalc0Mnlnbg?oc=5" target="_blank">Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Medicxi unveils €500m fund for asset-centric biotechs
Pharmaceutical Technologytech

Medicxi unveils €500m fund for asset-centric biotechs

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPU2JhNWlJTnQtZW43U2hYVFVydWNmbWJkVmNoeTN2Wk9jeVUzUVFLTldJT3BYa19RZGJwcUxkQ2dpSjlxT3pYRjJHamNNLUd6bE9aSmZFWVl1Vmk2NTdaNUV5X0g3QXhZM2EwaEVtZFdPMFBYU0pZTHU3SlA3VlRXbXJLeFh3bjFZdm01SjE5cV9RbXNPbDdYZGZnc1BsNmJVUE1F?oc=5" target="_blank">Medicxi unveils €500m fund for asset-centric biotechs</a>  <font color="#6f6f6f">Pharmaceutical Technology</font>

Read Full StoryMore like this
Amgen buys protein-degrading startup Dark Blue for up to $840M
BioPharma Divegeneral

Amgen buys protein-degrading startup Dark Blue for up to $840M

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5" target="_blank">Amgen buys protein-degrading startup Dark Blue for up to $840M</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Caldera, Vidya add to recent flurry of biotech mergers
BioPharma Divetech

Caldera, Vidya add to recent flurry of biotech mergers

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNNUs5NE12UEJKVmM0SUNRbkJxV2FVMkVMdUhSakxDS3QtRmZPZ08tSVpOcGk4c3NWUm82YjAwVnJzbXZRb3FEd1FwV0VoaFVGdmZqUmQyN2lBeExfMlFkdTc1cm0zaEYzc1FSTlM5eVdUV090RGRNeHVKUW52TFEwUkZ5eWlkYldITkwtS0diQ3hIOVd4LWc?oc=5" target="_blank">Caldera, Vidya add to recent flurry of biotech mergers</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Jeito hails $1.2B as 'largest raise ever' for independent biopharma-focused European fund
Fierce Biotechtech

Jeito hails $1.2B as 'largest raise ever' for independent biopharma-focused European fund

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOTVItUjc4MUZvUHp2RXptcVNELUUyS1dvMHZkaVhzZ0xWU1J2WWNnYzFCY3VCUWkyeDh2UFBaaFlkakg4aWxURFNoZmxKeFBEVkVnZDkzckJrcWt3MUVUZkxxZU02ZzNQdzQtYndQbU96ZHJHSE5jU0dCTldnUnBDRElzR3J0RTFyd1AwQjE2OF9JaG1yQXlvMTJQMU41X2VJUlRLYXpnNmJVbFNaLXdUU195S2tMS00?oc=5" target="_blank">Jeito hails $1.2B as 'largest raise ever' for independent biopharma-focused European fund</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Sanofi Ventures banks $625M to back young biotechs, digital health startups
BioPharma Divetech

Sanofi Ventures banks $625M to back young biotechs, digital health startups

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVm52WDJNLTlFQkNxTXRORk9NcTBYOTctckhkTzVZc25GSDdjMWVKbjVsUWgwTFFkLU8zZ3ExakdwcVlPZ1ZPZzVhdGlZZmxzWW16SEFxYk9paTN3TlZnOGNNLUhualZoVTBCVlZBSGJ4b1FmV3RHemRWSDQ1RHhhd2NfVGFydVJaLUlLOTNUbE1leHBpOUNwUllYS0FfanhmNjJtNmJpNlFZTW8?oc=5" target="_blank">Sanofi Ventures banks $625M to back young biotechs, digital health startups</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Biogen strikes deal with Versant-backed biotech to expand immune portfolio
BioPharma Divetech

Biogen strikes deal with Versant-backed biotech to expand immune portfolio

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU1dqcmZ2ZkFWMGU2WVlXUmtKVUNHbUVDa05VYmJOaE51TW42MlJQS05uaHRMWHZ3MTU0Q1lMUklfY2pfemYzUGUzVWhCNGhkd08yc2FLMFNNUElxTWlkSlhZSVV3NG9EMll1VnBtTFRVLWFVTGxPT2tpckR4U0dJLS1WSXMxX05fbkg3ckIxOFBpR01VbGd0bFAySExQRVA5VlZiMnNlQUNzNmN5Um1RSFhVQ25Xam5N?oc=5" target="_blank">Biogen strikes deal with Versant-backed biotech to expand immune portfolio</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
"Medicxi closes sixth fund" — Live Google News Trends & Headlines